The importance of local-regional radiotherapy with conventional or high- dose chemotherapy in the management of breast cancer patients with ≥ 10 positive axillary nodes

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 2, 1999, Pages 273-280

  Jabro, Gina ^a   Wazer, David E ^a   Ruthazer, Robin ^a   Lum, Ryan ^b   Sklar, Naomi ^b   Goldman, Deborah ^b   Enegess, Deborah ^b   Erban, John ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Extensive nodal disease; Radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; TAMOXIFEN; THIOTEPA;

ADULT; ADVANCED CANCER; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TAMOXIFEN; TREATMENT FAILURE;

EID: 0032913648     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00009-7     Document Type: Article

References (25)

1. Carter C.L., Allen C., Henson D.E. Relationship of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 63:1989;181-187.
2. Fisher B., Redmond C., Fisher E.R., Bauer M., Wolmark N., Wickerham D.L., Deutsch M., Montague E., Margolese R., Foster R. 10 year results of a randomized trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med. 312:1985;674-681.
3. Donegan W.L., Lewis D. Clinical diagnosis and staging of breast cancer. Semin Oncol. 5:1978;373-384.
4. Fisher E.R., Gregorio R.M., Fisher B., Redmond C., Vellios F., Sommers S. The pathology of invasive breast cancer. Cancer. 36:1975;1-85.
5. Nemoto T., Vara J., Bedwani R.N., Baker H.W., McGregor F.H., Murphy G.P. Management and survival of female breast cancer results of a national survey of the American College of Surgeons . Cancer. 45:1980;2917-2924.
6. Fowble B., Gray R., Gilchrist K., Goodman R., Taylor S., Tormey C. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol. 6:1988;1107-1111.
7. Fowble B. Postmastectomy radiation Then and now . Oncology. 11:1997;213-239.
8. Ung O., Langlands A.O., Barraclough B., Boyages J. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement. J Clin Oncol. 13:1993;435-443.
9. Buzdar A.U., Kau S., Hortobagyi G.N., Ames F.C., Holmes F.A., Fraschini G., Hug V., Theriault R.L., McNeese M., Singletary S.E. Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy. Cancer. 69:1992;448-452.
10. Peters W.P., Ross M., Vredenburgh J.J., Meisenberg B., Marks L.B., Winer E., Kurtzberg J., Bast R.C., Jones R. High dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol. 11:1993;1132-1143.
11. Razis E., Samonis G., Cook R., Beer M., Mittleman A., Lake D., Feldman E., Puccio C., Ahmed T. TMJ A well tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer . J Med. 25:1994;241-250.
12. Solmo G, Doroshow JH, Forman SJ, Leong LA, Margolin KA, Morgan RJ, Nagasawa S, Harrison J. High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. Cancer 1994;15:1679-1185.
13. Gianni A.M., Siena S., Bregni M.D., Nicola M., Orefice S., Cusumano F., Salvadori B., Luini A., Greco M., Zucali R., Rilke F., Zambetti M., Valagussa P., Bonadonna G. Efficacy, toxicity and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes; 5 year results. J Clin Oncol. 15:1997;2312-2321.
14. Bonadonna G., Zambetti M., Valagussa P. Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. JAMA. 273:1995;542-547.
15. Davidson N., Abeloff M. Adjuvant systemic therapy in women with early-stage breast cancer at high risk for relapse. J Natl Cancer Inst. 84:1992;301-305.
16. Spitzer T.R., Cirenza E., McAfee S., Foelber R., Zarzin J., Cahill R., Mazumder A. Phase I-II trial of high-dose cyclophosphamide, carboplatin and autologous bone marrow or perpheral blood stem cell rescue. Bone Marrow Transpl. 15:1995;537-542.
17. Overgaard M., Hansen P., Overgaard J., Rose C., Andersson M., Bach F., Kjaer M., Gadeberg C., Mouridsen H., Jensen M., Zedeler K. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 337:1997;949-955.
18. Ragaz J., Jackson S., Le N., Plenderleith I., Spinelli J., Basco V., Wilson K., Knowling M., Coppin C., Paradis M., Coldman A., Olivotto I. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 337:1997;956-962.
19. Diab S.G., deMoor C.A., Clark G.M., Osborne P.M., Ravdin P.M., Elledge R.M. Radiation therapy improves survival by decreasing local failure in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy. (Abstr.) Proc ASCO. 16:1997;130a.
20. Fowble B., Solin L., Schultz D.J., Goodman R.L. Frequency, sites of relapse, and outcome of regional node failure following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys. 17:1989;703-710.
21. Haffty B.G., Fischer D., Fischer J.J. Regional nodal irradiation in the conservative treatment of breast cancer. Int J Radiat Oncol Biol Phys. 19:1990;859-865.
22. Halverson K., Perez C., Kuske R., Garcia D.M., Simpson J.R., Fineberg B. Isolated local-regional recurrence of breast cancer following mastectomy Radiotherapeutic management . Int J Radiat Oncol Biol Phys. 19:1990;851-858.
23. Hoskin P.J., Rajan B., Ebbs S., Tait D., Milan S., Qarnold J.R. Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer. Radiother Oncol. 25:1992;83-88.
24. Mehta K., Haffty B.G. Long term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 35:1996;679-685.
25. Marks L.B., Halperin E.C., Prosnitz L.R., Ross M., Vredenburgh J.J., Rosner G.L., Peters W. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary nodes. Int J Radiat Oncol Biol Phys. 23:1992;1021-1026.